KalVista Pharmaceuticals Inc.

NASDAQ: KALV
Share price (3/25/25): $12.50
Market cap (3/25/25): $621 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 01/31/25 Q3

ended 10/31/24 Q2

ended 07/31/24 Q1

ended 04/30/24 FY 2024

ended 01/31/24 Q3

Prospectuses and Registrations Filter

Registration of securities for employees

Prospectus supplement for primary offering

Shelf registration

Registration of securities for employees

Prospectus supplement for primary offering

Ownership Filter

Palleiko Benjamin L

Palleiko Benjamin L

Yea Christopher

News Filter

Amendment to Articles of Incorporation or Bylaws, or Change in Fiscal Year

Reports Third Fiscal Quarter Results and Provides Operational Update

Appoints Jeb Ledell as Chief Operating Officer

Reports Second Fiscal Quarter Results and Provides Operational Update

Appoints Laurence Reid, Ph.D., to Board of Directors

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Preliminary proxy

Other Filter

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Scanned paper annual report submission